COVID-19 viral activity was high in the United States during the first week of September, according to fresh data from the Centers for Disease Control and Prevention. Some regions of the United States ...

This year’s updated Covid-19 vaccines have been approved by the US Food and Drug Administration for adults 65 and older and younger people with certain medical conditions that put them at a higher ...

Novel Coronavirus (COVID-19) The COVID-19 pandemic caused by the novel coronavirus (SARS-CoV-2) continues to reshape the globe. Stay current with the latest updates essential for healthcare ...

Amid the declining clinical severity of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection and diminishing public uptake of annual coronavirus disease 2019 (Covid-19) vaccines, ...

Nirmatrelvir in combination with ritonavir is an antiviral treatment for mild-to-moderate coronavirus disease 2019 (Covid-19). The efficacy of this treatment in patients who are at standard risk for ...